Long-term Effects of Lifestyle Intervention During Pregnancy in High Risk Women and in Their Offspring - Role of Environmental, Genetic and Epigenetic Factors

NCT ID: NCT02048839

Last Updated: 2019-04-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

680 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-31

Study Completion Date

2017-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

SUBJECTS:

All participants in the RADIEL-study (2008-2011) who delivered (n=535), will be invited to this follow-up study, with their children (age 3-5 years) and the father. The investigations are carried out during two separate visits. The father receives mail questionnaires

OVERALL OBJECTIVES:

1. To determine the long-term effectiveness of a lifestyle intervention in high risk women and their offspring a in reducing the incidence of T2DM and cardiovascular disease and their risk factors b in preventing obesity c on biomarkers d on genetic and epigenetics markers .
2. To study the association between maternal diet during pregnancy and metabolic markers in the offspring at age 3-5 years.
3. To study the association between maternal exercise habits during pregnancy and metabolic markers in the offspring at age 3-5 years.
4. To study the association between maternal a) glucose-insulin metabolism b) lipid metabolism c) adipoinsulinar axis and d) inflammatory markers and birth size and later health outcomes in the mothers and their offspring.
5. To study the association between gut microbiota and markers of offspring health
6. To study associations between offspring cardiovascular morphology/function, offspring body size/composition, and maternal cardiovascular risk
7. To study the cost effectiveness of the intervention.

METHODS:

Maternal measurements

1. Height, weight, waist and hip circumference
2. Blood pressure, pulse
3. Body fat percentage
4. Blood tests e.g. markers of glucose metabolism and lipids, vitamin D, Calcium and bone markers, DNA sample and inflammation markers
5. Fecal and hair samples
6. Diurnal salivary cortisol assessment
7. Background questionnaire: socioeconomic and health-related background
8. Health-related quality of life (15-D).
9. 3-day food diary and exercise diary
10. ArmBand (acceleration sensor), assessment of physical activity and sleep for 7 days
11. Psychological questionnaires
12. Pulse wave velocity (PWV) will be assessed
13. Advanced glycation endproducts - a marker of cardiovascular health will be assessed
14. Dental and oral health
15. Bone health
16. VHRU of arterial structure

Paternal measurements

1. Background questionnaire (incl. height, weight, age)
2. DNA-sample (buccal)
3. 3-day food diary
4. Psychological questionnaires
5. Physical activity questionnaire (12 months)

Measurements of children

1. Body weight, height, blood pressure, pulse
2. Body fat percentage
3. Psychological questionnaires
4. Food and physical activities diaries
5. ActiGraph, assessment of physical activity and sleep for 7 days
6. Blood samples e.g. glucose- and insulin metabolism, lipids, vitamin D and calcium metabolism, DNA-sample and samples for inflammation markers
7. Fecal, urine and hair samples
8. A copy of child welfare center card (e.g. data on growth, immunizations, health)
9. Endothelial function and pulse wave velocity (PWV)
10. Bone health with peripheral CT
11. Heart structure and function
12. VHRU of arterial structure

TIMETABLE

Follow up starts in January 2014, and will continue until 2018. Data analysis starts in 2017 and results will be reported from 2018 onwards in international peer-reviewed journals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Obesity Metabolic Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Radiel Intervention group and their children

Participated the Radiel- intervention study (2008-2011) in the Intervention group: Lifestyle counselling during and after pregnancy (up to 1 year post partum)

No interventions assigned to this group

Radiel Control Group with their children

Control group in the Radiel- intervention study.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all study subjects form Radiel intervention study, who delivered a baby

Exclusion Criteria

* none.
Minimum Eligible Age

3 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Helsinki University Central Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Saila Koivusalo

MD PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Helsinki University

Helsinki, , Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Radiel 5Y

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

RESTORE - Phase II
NCT06349070 ENROLLING_BY_INVITATION NA
Oral Health and Pregnancy
NCT04992754 UNKNOWN
Navigation Study: Durham
NCT04438031 ACTIVE_NOT_RECRUITING NA
LARC Forward Counselling
NCT03269357 COMPLETED NA